Tarsus Pharmaceuticals insider files Form 144 for November share sale

au.investing.com —

Tarsus Pharmaceuticals Inc. filed a Form 144 with the SEC on November 15, 2026, indicating a proposed sale of company shares by an insider. The filing is a notice of intent to sell restricted or controlled stock, commonly used by executives or major shareholders. It does not specify the number of shares or the seller's identity in the provided text. Form 144 is a routine regulatory disclosure required before insider sales, and it does not necessarily reflect the company's operational performance or financial health.


With a significance score of 0.9, this news ranks in the top 74% of today's 30826 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: